INVESTIGATION ALERT (NASDAQ: SEZL): DiCello Levitt LLP Is Investigating Investor Claims Against Sezzle Inc. and Encourages SEZL Investors with Losses to Contact the Firm
20 déc. 2024 14h35 HE
|
DiCello Levitt LLP
SAN DIEGO, Dec. 20, 2024 (GLOBE NEWSWIRE) -- DiCello Levitt LLP announces that it is investigating whether Sezzle Inc. (“Sezzle” or the “Company”) (NASDAQ: SEZL) complied with federal securities...
Regenx Grants Stock Options
19 déc. 2024 11h22 HE
|
Regenx Tech Corp.
Regenx Tech Corp. grants 5.7M stock options at $0.05/share to directors, officers & consultants. 1.8M options from 2019 expired in 2024.
Notice of General Meeting
07 nov. 2024 16h30 HE
|
Biodexa Pharmaceuticals PLC
November 7, 2024 Biodexa Pharmaceuticals PLC(“Biodexa” or the “Company”) Notice of General Meeting Biodexa Pharmaceuticals PLC, (Nasdaq: BDRX), a clinical stage biopharmaceutical company developing...
Marex Group plc Announces Pricing of the Public Offering
24 oct. 2024 09h00 HE
|
Marex Group plc
MAREX GROUP PLC ANNOUNCES PRICING OF THE PUBLIC OFFERING
ROSEN, GLOBAL INVESTOR COUNSEL, Encourages WEBTOON Entertainment Inc. Investors to Secure Counsel Before Important Deadline in Securities Class Action – WBTN
06 oct. 2024 19h11 HE
|
The Rosen Law Firm PA
NEW YORK, Oct. 06, 2024 (GLOBE NEWSWIRE) -- WHY: Rosen Law Firm, a global investor rights law firm, reminds purchasers of common stock of WEBTOON Entertainment Inc. (NASDAQ: WBTN) pursuant...
ROSEN, LEADING TRIAL ATTORNEYS, Encourages Terran Orbital Corporation Investors to Secure Counsel Before Important Deadline in Securities Class Action First Filed by the Firm – LLAP
06 oct. 2024 15h33 HE
|
The Rosen Law Firm PA
NEW YORK, Oct. 06, 2024 (GLOBE NEWSWIRE) -- WHY: Rosen Law Firm, a global investor rights law firm, announces it has filed a class action lawsuit on behalf of purchasers of securities of Terran...
CoinShares Announces Exercise of Employee Incentive Plan Options
11 sept. 2024 12h44 HE
|
CoinShares International Limited
11 September 2024 | SAINT HELIER, Jersey | CoinShares International Limited (“CoinShares'' or “the Company”) (Nasdaq Stockholm: CS; US OTCQX: CNSRF). On 11 September 2024, a total of 55,720...
OKYO Pharma Announces Chairman Acquires Shares
10 sept. 2024 07h00 HE
|
OKYO Pharma LTD
LONDON and NEW YORK, Sept. 10, 2024 (GLOBE NEWSWIRE) -- OKYO Pharma Limited (NASDAQ: OKYO), a clinical-stage biopharmaceutical company developing innovative ocular therapies for the treatment of...
OKYO Pharma Announces Chairman Acquires Shares
05 sept. 2024 07h00 HE
|
OKYO Pharma LTD
LONDON and NEW YORK, Sept. 05, 2024 (GLOBE NEWSWIRE) -- OKYO Pharma Limited (NASDAQ: OKYO), a clinical-stage biopharmaceutical company developing innovative ocular therapies for the treatment of...
OKYO Pharma Announces Chairman Acquires Shares
23 août 2024 07h00 HE
|
OKYO Pharma LTD
LONDON and NEW YORK, Aug. 23, 2024 (GLOBE NEWSWIRE) -- OKYO Pharma Limited (NASDAQ: OKYO), a clinical-stage biopharmaceutical company developing innovative ocular therapies for the treatment of...